Effect of Chenopodium ambrosioides (paico) powder on lipid metabolism markers in rat liver, compared to ethanol and fructose consumption.
DOI:
https://doi.org/10.12873/444puellesKeywords:
Hepatoprotección, Chenopodium ambrosioides, etanol, fructosa, alimento funcionalAbstract
Introduction: Chronic liver diseases (CLD) have a high morbidity and mortality rate worldwide, with an alarming increasing trend; liver cirrhosis being the final stage and the most frequent chronic expression of liver disease. Objective: To evaluate the effect of Chenopodium ambrosioides (paico) spray versus ethanol and fructose consumption in rat liver. Materials and methods: Experimental design. Twenty-five male rats were used. For the induction of hepatotoxicity, which lasted 22 days, a mixture of 5% ethanol/15% fructose was administered in their drinkers to groups II-V, while group I received only water. Paico spray was added to the balanced diet at 1% (group III), 3% (group IV) and 9% (group V), while groups I-II received a balanced diet. After treatment and 10 hours of fasting, the animals were anesthetized with sodium pentobarbital, and the liver was then removed. Three portions were sectioned for histological analysis and two for homogenate preparation, where molecular markers were determined. Results: Consumption of 3% paico increased PPAR-α levels, while PPAR-γ increased in groups III, IV, and V. SREBP was more inhibited at 3% paico. The PPAR-α/SREBP and Ppar-γ/SREBP ratios increased in relation to the percentage of paico. Conclusions: Consumption of Chenopodium ambrosioides (paico) powder has a hepatoprotective effect at a medium dose for the model studied.
References
Coronado M. Antioxidantes: perspectiva actual para la salud humana. Rev Chil Nutr. 2015;42(2).
Organización Mundial de la Salud. Las 10 principales causas de defunción. 2018. Disponible en: http://www.who.int/es/news-room/fact-sheets/detail/the-top-10-causes-of-death.
Paredes J. Efecto del pulverizado de la cáscara del Mangifera indica H.(mango) sobre la toxicidad hepática inducida por etanol en ratones. 2020.
Blachier, M. The burden of liver disease in Europe: a review of available epidemiological data. Journal of hepatology. 2013. 58(3), 593-608.
Prieto, J. Características clínicas y descompensación en pacientes con cirrosis hepática atendidos en dos centros de hepatología en la ciudad de Bogotá DC, 2010-2014. Revista colombiana de Gastroenterología. 2016. 31(1), 1-8.
Fulgencio S. Antioxidantes macromoleculares: importancia en salud y perspectivas. Arch Med Deporte. 2017; 34(4):188-189.
Salazar D. Utilización de semilla de papaya (carica papaya) y paico (chenopodium ambrosoides) como antiparasitario natural en perros de la ciudad de Latacunga (Bachelor's thesis, Ecuador: Latacunga: Universidad Técnica de Cotopaxi (UTC)). 2021.
Castellanos J. Epazote (Chenopodium ambrosioides). Revisión a sus características morfológicas, actividad farmacológica, y biogénesis de su principal principio activo, ascaridol. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas. 2008. 7(1), 3-9.
Rui-Hua, Q. Essential oil from Chenopodium ambrosioides L. Induces mitochondrial-mediated pathway and endoplasmic reticulum stress-related apoptosis in human liver cancer SMMC-7721 cells. Tropical Journal of Pharmaceutical Research. 2020; 19(4), 837–843. https://doi.org/10.4314/tjpr.v19i4.23
Skat-Rørdam, J. A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease. Basic and Clinical Pharmacology and Toxicology. 2019; 124(5), 528–537. https://doi.org/10.1111/bcpt.13190.
Souza, V. Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. World Journal of Hepatology. 2015; 7(8), 1012–1019. https://doi.org/10.4254/wjh.v7.i8.1012.
Gajender. A Comprehensive Review of the Pharmacological Importance of Dietary Flavonoids as Hepatoprotective Agents. Evidence-Based Complementary and Alternative Medicine. 2023. https://doi.org/10.1155/2023/4139117.
Barros, L. Bioactivity and chemical characterization in hydrophilic and lipophilic compounds of Chenopodium ambrosioides L. Journal of Functional Foods. 2013; 5(4), 1732–1740. https://doi.org/10.1016/j.jff.2013.07.019
Fang, X. Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease. Molecules. 2023; 28(15). https://doi.org/10.3390/molecules28155645
Li, X. Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease. World Journal of Hepatology. 2022; 14(7), 1365–1381. https://doi.org/10.4254/wjh.v14.i7.1365
Song, M. Antidiabetic effect of Chenopodium ambrosioides. Phytopharmacology. 2011; 1(2), 12–15.
Zhang, C. Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy. World Journal of Hepatology. 2023; 15(2), 180–200. https://doi.org/10.4254/wjh.v15.i2.180.
Gómez, J. Epazote (Chenopodium ambrosioides). Revisión a sus características morfológicas, actividad farmacológica, y biogénesis de su principal principio activo, ascaridol. Boletin Latinoamericano y Del Caribe de Plantas Medicinales y Aromaticas. 2008; 7(1), 3–9.
Wang, Y. PPARs as metabolic regulators in the liver: Lessons from liver-specific PPAR-null mice. International Journal of Molecular Sciences. 2020; 21(6). https://doi.org/10.3390/ijms21062061.
Tan, P. Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease. Frontiers in Pharmacology. 2022; 1–10. https://doi.org/10.3389/fphar.2022.1005312.
Lee, S. Role of hepatic peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease. Journal of Endocrinology. 2023; 257(1). https://doi.org/10.1530/JOE-22-0155.
Enayati, A. Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments. PPAR Research, 2022. https://doi.org/10.1155/2022/4714914.
Li, H. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease. Alcoholism: Clinical and Experimental Research. 2014; 38(6), 1520–1531. https://doi.org/10.1111/acer.12424.
Pan, J. Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease. Biomedicine and Pharmacotherapy. 2022; 113-127. https://doi.org/10.1016/j.biopha.2022.113127.
Delgado, M. Evaluación del efecto de infusión de hojas de apazote (Chenopodium ambrosioides) administrada por vía oral, en el agua de bebida, para el control de ascaridos intestinales en aves de traspatio en la ciudad de Guatemala. 2013. http://www.repositorio.usac.edu.gt/2271/
Xu, Y. Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. Frontiers in Pharmacology, 2020. https://doi.org/10.3389/fphar.2020.00601.
FIGUEROA, A. CAPACIDAD ANTIOXIDANTE Y COMPUESTOS BIOACTIVOS: ÁCIDOS GRASOS, POLIFENOLES, TERPENOS Y TOCOFEROLES EN HOJAS DE PAICO Dysphania ambrosioides (L.) Mosyakin & Clemants. Universidad Nacional Agraria La Molina. 2021.
Sun, X. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease. Acta Pharmaceutica, 2017; 67(1), 1–13. https://doi.org/10.1515/acph-2017-0007.
Wu, L. Therapeutic potential of PPARγ natural agonists in liver diseases. Journal of Cellular and Molecular Medicine. 2020; 24(5), 2736–2748. https://doi.org/10.1111/jcmm.15028.
Li, J. Chemical composition of the volatile oil of Chenopodium ambrosioides L. From Mianyang in Sichuan Province of China and its sub-chronic toxicity in mice. Tropical Journal of Pharmaceutical Research. 2020; 19(9), 1985–1991. https://doi.org/10.4314/tjpr.v19i9.26.
Downloads
Published
How to Cite
License
Copyright (c) 2024 Nutrición Clínica y Dietética Hospitalaria
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los lectores pueden utilizar los textos publicados de acuerdo con la definición BOAI (Budapest Open Access Initiative)
